Kwon N - Search Results

1

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies.

Kim MK, Park HS, Park CS, Min SJ, Albers FC, Yancey SW, Mayer B, Kwon N. Kim MK, et al. Among authors: kwon n. Korean J Intern Med. 2021 Mar;36(2):362-370. doi: 10.3904/kjim.2019.198. Epub 2020 May 26. Korean J Intern Med. 2021. PMID: 32450626 Free PMC article.

2

Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome.

Pane F, Lefevre G, Kwon N, Bentley JH, Yancey SW, Steinfeld J. Pane F, et al. Among authors: kwon n. Front Immunol. 2022 Aug 26;13:935996. doi: 10.3389/fimmu.2022.935996. eCollection 2022. Front Immunol. 2022. PMID: 36091012 Free PMC article. Clinical Trial.

3

Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.

Albers FC, Licskai C, Chanez P, Bratton DJ, Bradford ES, Yancey SW, Kwon N, Quirce S. Albers FC, et al. Among authors: kwon n. Respir Med. 2019 Nov;159:105806. doi: 10.1016/j.rmed.2019.105806. Epub 2019 Nov 3. Respir Med. 2019. PMID: 31751853 Free article.

4

Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma.

Howarth P, Quirce S, Papi A, Israel E, Mallett S, Bates S, Yancey S, Albers FC, Kwon N. Howarth P, et al. Among authors: kwon n. Allergy. 2020 Aug;75(8):2085-2088. doi: 10.1111/all.14266. Epub 2020 Mar 23. Allergy. 2020. PMID: 32147844 Free PMC article. No abstract available.

5

Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma.

Wardlaw A, Howarth PH, Israel E, Taillé C, Quirce S, Mallett S, Bates S, Albers FC, Kwon N. Wardlaw A, et al. Among authors: kwon n. Clin Exp Allergy. 2020 Jul;50(7):869-872. doi: 10.1111/cea.13680. Epub 2020 Jun 25. Clin Exp Allergy. 2020. PMID: 32515118 Free PMC article. Clinical Trial. No abstract available.

6

Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.

Humbert M, Albers FC, Bratton DJ, Yancey SW, Liu MC, Hozawa S, Llanos JP, Kwon N. Humbert M, et al. Among authors: kwon n. Respir Med. 2019 Jul-Aug;154:69-75. doi: 10.1016/j.rmed.2019.06.004. Epub 2019 Jun 8. Respir Med. 2019. PMID: 31220806 Free article.

7

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.

Albers FC, Papi A, Taillé C, Bratton DJ, Bradford ES, Yancey SW, Kwon N. Albers FC, et al. Among authors: kwon n. Respir Res. 2019 Jul 30;20(1):169. doi: 10.1186/s12931-019-1134-7. Respir Res. 2019. PMID: 31362741 Free PMC article. Clinical Trial.

8

Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome.

Reiter A, Lefevre G, Cid MC, Kwon N, Mavropolou E, Yancey SW, Steinfeld J. Reiter A, et al. Among authors: kwon n. Front Immunol. 2022 Apr 13;13:840974. doi: 10.3389/fimmu.2022.840974. eCollection 2022. Front Immunol. 2022. PMID: 35493455 Free PMC article. Clinical Trial.

9

Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.

Rothenberg ME, Roufosse F, Faguer S, Gleich GJ, Steinfeld J, Yancey SW, Mavropoulou E, Kwon N; HES Mepolizumab Study Group. Rothenberg ME, et al. Among authors: kwon n. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2367-2374.e3. doi: 10.1016/j.jaip.2022.04.037. Epub 2022 May 12. J Allergy Clin Immunol Pract. 2022. PMID: 35568330 Free article. Clinical Trial.

10

Characteristics and treatment regimens across ERS SHARP severe asthma registries.

van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlén B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Škrgat S, Sont JK, Vijverberg SJH, Weersink EJM, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP Clinical Research Collaboration; Members of the SHARP Clinical Research Collaboration are. van Bragt JJMH, et al. Among authors: kwon n. Eur Respir J. 2020 Jan 9;55(1):1901163. doi: 10.1183/13993003.01163-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31601713 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

505 results

Search Page